Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jul 9, 2007

Pluristem and German Center for Regenerative Therapies Ink Research Deal

  • Pluristem Life Systems inked a research agreement with the Berlin-Brandenburg Center for Regenerative Therapy (BCRT) at Charité-University Medicine Berlin. Pluristem and BCRT will explore a variety of indications utilizing mesenchymal stem cells (MSCs) derived from the placenta that have been expanded in the company’s PluriX™ 3-D bioreactor.

    The initial focus of the alliance will be on neurological indications such as multiple sclerosis and Parkinson’s disease. The agreement also covers organ transplantation and cardiovascular indications like inflammatory cardiomyopathy. Pluristem will be the exclusive owner of the technology and any products stemming from the collaboration.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »